Singapore Pharmaceutical Excipient Market Analysis

Singapore Pharmaceutical Excipient Market Analysis


$ 3999

Singapore Pharmaceutical Excipient market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Excipient is growing rapidly as a result of growing Pharmaceutical Industry, Generic Drug Production driven by patent expiration and cost considerations, drug delivery systems advncements like such as controlled-release formulations, nanoparticles, and transdermal patches, requires specialized excipients to achieve the desired drug release profiles. Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Dow, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, Chemie Trade are the key global market players.

ID: IN10SGPH367 CATEGORY: Pharmaceuticals GEOGRAPHY: Singapore AUTHOR: Dr. Netal Patel

Buy Now

Singapore Pharmaceutical Excipient Market Analysis Summary

Singapore Pharmaceutical Excipient Market is valued at around $10.3 Mn in 2022 and is projected to reach $17.2 Mn by 2030, exhibiting a CAGR of 6.59% during the forecast period 2023-2030.

The formulation and production of pharmaceutical goods heavily rely on the pharmaceutical excipient sector. To develop a final dosage form, active pharmaceutical ingredients (APIs) are mixed with excipients, which are inert chemicals. Excipients are included in a pharmaceutical dosage form to assist in the manufacturing process to protect, support, or enhance stability, or for bioavailability. They also help to identify products and improve general product safety or functionality during storage or use. The surge in the generics market and rising focus on orphan drugs are the market drivers. Excipients are of different types like Binders, Fillers, Disintegrants, Lubricants, Coatings, Preservatives, Antioxidants, sweeteners, etc. Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Dow, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, and Chemie Trade are the key global market players.

Market Dynamics

Market Growth Drivers

Growing Pharmaceutical Industry, Generic Drug Production driven by patent expiration and cost considerations, drug delivery systems advances such as controlled-release formulations, nanoparticles, and transdermal patches, require specialized excipients to achieve the desired drug release profiles.

Market Restraints

Increasing regulatory stringency regarding the approval of excipients, along with the increase in cost and time-intensive drug development process, increasing emphasis on sustainable and environmentally friendly manufacturing practices in the pharmaceutical industry influences the selection of excipients with minimal environmental impact. All these factors act as market growth restraints.

Competitive Landscape

Key Players

  • Kerry Group plc.
  • DFE Pharma
  • Cargill
  • Incorporated
  • Pfanstiehl
  • Colorcon
  • MEGGLE GmbH & Co. KG
  • Omya AG
  • Peter Greven GmbH & Co. KG
  • Ashland.
  • Evonik
  • Dow
  • Croda International Plc
  • Roquette Frères.
  • The Lubrizol Corporation
  • BASF SE
  • Avantor, Inc.
  • BENEO
  • Chemie Trade

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Singapore Pharmaceutical Excipient market

By Functionality

  • Binders And Adhesives
  • Disintegrants
  • Coating Material
  • Colouring Agents
  • Solubilizers
  • Flavours
  • Sweetening Agents
  • Diluents
  • Lubricants
  • Buffers
  • Emulsifying Agents
  • Preservatives
  • Antioxidants
  • Sorbents
  • Solvents
  • Emollients
  • Glidents
  • Chelating Agents
  • Antifoaming Agents
  • Others

By Dosage Form

  • Solid
  • Semi-Solid
  • Liquid

By Route of Administration

  • Oral Excipients
  • Topical Excipients
  • Parenteral Excipients
  • Other Excipients

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Formulators
  • Research Organization and Academics
  • Others

By Distribution Channel

  • Direct Tender
  • Retail Sales
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up